USPTO serial 97703813
PROFOUNDBIO
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- JOHN, CRISTEL M
- Law office
- TMO LAW OFFICE 125
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PROFOUNDBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Woodinville, WA, US
VALBY, DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Paulo A. de Almeida
Paulo A. de Almeida Patel & Almeida PC22543 Ventura Blvd, Ste 220 #1200Woodland Hills, CA 91364UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and therapeutic pharmaceutical preparations for the treatment and diagnosis of cancer and immunological diseases, disorders and conditions; pharmaceutical and therapeutic pharmaceutical preparations based on antibodies, namely, mono-, bi- and multi-specific antibodies, antigen binding fragments of the antibodies, and other targeting agents or conjugates of any of these for use with regard to the treatment and diagnosis of cancer, infectious, immune, autoimmune, and inflammatory diseases, disorders and conditions | ACTIVE | — |
| 042 | Research and development of pharmaceuticals and therapeutic preparations for the treatment of mono-, bi- and multi-specific antibodies, antigen binding fragments of the antibodies, and other targeting agents or conjugates of any of these for use with regard to the treatment and diagnosis of cancer, infectious, immune, autoimmune, and inflammatory diseases, disorders and conditions; medical research services in the field of cancer and immunological diseases, disorders and conditions; clinical research in the field of cancer and immunological diseases, disorders and conditions | ACTIVE | — |
| 044 | Providing healthcare and medical information in the field of cancer and immunological diseases, disorders and conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 23, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 25, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 22, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 20, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 19, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 8, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 8, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 8, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 3, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 3, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 3, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 3, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 2, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 2, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 2, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 26, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 12, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 8, 2022 | NWAP | NEW APPLICATION ENTERED | — |